Baird Downgrades Praxair Inc. (PX) to Neutral

Baird downgraded Praxair Inc. (NYSE: PX) from Outperform to Neutral with a price target of $133.00 (from $136.00).

For an analyst ratings summary and ratings history on Praxair Inc. click here. For more ratings news on Praxair Inc. click here.

Shares of Praxair Inc. closed at $126.34 yesterday.

You May Also Be Interested In

• Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
• Shanghai Conant Optical (2276:HK) PT Lowered to HK$81.40 at Macquarie
• Giant Biogene Holding Co (2367:HK) PT Raised to HK$46 at Macquarie